Grifols (GRFS) Sales of Property, Plant and Equipment (2010 - 2016)
Grifols (GRFS) Sales of Property, Plant and Equipment (2010 - 2016) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Sales of Property, Plant and Equipment (Qtr) |
| 1 |
Eli Lilly |
1,066.16 Bn |
1,060.88 Bn |
16.22 Bn |
- |
| 2 |
Johnson & Johnson |
611.69 Bn |
589.64 Bn |
15.96 Bn |
29.00 Mn |
| 3 |
AbbVie |
444.34 Bn |
434.99 Bn |
10.78 Bn |
- |
| 4 |
Astrazeneca |
284.94 Bn |
277.05 Bn |
12.61 Bn |
-8.00 Mn |
| 5 |
Merck |
224.23 Bn |
218.58 Bn |
12.09 Bn |
- |
| 6 |
Amgen |
195.12 Bn |
183.08 Bn |
5.87 Bn |
- |
| 7 |
Gilead Sciences |
156.45 Bn |
148.73 Bn |
5.52 Bn |
- |
| 8 |
Pfizer |
136.01 Bn |
123.24 Bn |
-1.21 Bn |
- |
| 9 |
Novartis Ag |
113.45 Bn |
113.67 Bn |
- |
5.00 Mn |
| 10 |
Grifols |
- |
- |
- |
- |
| Date | Value |
|---|
| Dec 31, 2016 |
336,873.96 |
| Dec 31, 2016 |
336,873.96 |
| Sep 30, 2016 |
401,826.41 |
| Sep 30, 2016 |
401,826.41 |
| Dec 31, 2015 |
174,282.65 |
| Dec 31, 2015 |
174,282.65 |
| Sep 30, 2015 |
104,554.78 |
| Sep 30, 2015 |
104,554.78 |
| Jun 30, 2015 |
765,862.90 |
| Jun 30, 2015 |
765,862.90 |
| Mar 31, 2015 |
15.10 Mn |
| Mar 31, 2015 |
15.10 Mn |
| Dec 31, 2014 |
-18.04 Mn |
| Dec 31, 2014 |
-18.04 Mn |
| Sep 30, 2014 |
18.61 Mn |
| Sep 30, 2014 |
18.61 Mn |
| Jun 30, 2014 |
358,058.52 |
| Jun 30, 2014 |
358,058.52 |
| Mar 31, 2014 |
528,961.07 |
| Mar 31, 2014 |
528,961.07 |
